Related Experiment Video
Updated: Jun 22, 2026
09:29
Isolation of Targeted Hypothalamic Neurons for Studies of Hormonal, Metabolic, and Electrical Regulation
Published on: August 4, 2023
Hypocretin/orexin and narcolepsy: new basic and clinical insights
S Nishino1, M Okuro, N Kotorii
1Stanford University, Sleep and Circadian Neurobiology Laboratory, Palo Alto, CA 94304-5489, USA. nishino@stanford.edu
Acta Physiologica (Oxford, England)
|June 27, 2009
Summary
Narcolepsy is a chronic sleep disorder linked to hypocretin deficiency. Low cerebrospinal fluid hypocretin-1 levels are a key diagnostic marker, paving the way for potential hypocretin replacement therapies.
Area of Science:
- Neuroscience
- Sleep Medicine
- Genetics
Background:
- Narcolepsy is a chronic sleep disorder with symptoms including excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, and hallucinations.
- Both sporadic and familial forms exist, with recent research focusing on the hypocretin/orexin system.
Purpose of the Study:
- To summarize the current understanding of narcolepsy pathophysiology, focusing on hypocretin ligand deficiency.
- To highlight the diagnostic implications of hypocretin levels and explore potential therapeutic strategies.
Main Methods:
- Review of recent discoveries in narcolepsy genetics and pathophysiology.
- Analysis of hypocretin-related gene mutations and hypocretin ligand deficiency in human narcolepsy.
- Examination of hypocretin deficiency in symptomatic narcolepsy and related neurological conditions.
Main Results:
- Hypocretin ligand deficiency is prevalent in narcolepsy with cataplexy, likely due to hypocretin neuron cell death.
- Low cerebrospinal fluid hypocretin-1 levels are established as a diagnostic test for narcolepsy with cataplexy and narcolepsy due to medical conditions.
- Hypocretin deficiency is also observed in symptomatic narcolepsy associated with neurological disorders.
Conclusions:
- Hypocretin deficiency is a central mechanism in human narcolepsy.
- Measurement of cerebrospinal fluid hypocretin-1 is a valuable diagnostic tool.
- Hypocretin replacement therapy represents a promising future treatment for narcolepsy.
More Related Videos
08:58Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
10:45Simultaneous Electroencephalography, Real-time Measurement of Lactate Concentration and Optogenetic Manipulation of Neuronal Activity in the Rodent Cerebral Cortex
Published on: December 19, 2012
Related Concept Videos
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:11Understanding Sleep
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...